Advertisement
Home »

Antidepressant effects of novel positive allosteric modulators of Trk-receptor mediated signaling – a potential therapeutic concept?

Jul 03, 2023

ABOUT THE EXPERTS

  • Nather Madjid

    AlzeCure Pharma AB, Hälsovägen 7, 141 57, Huddinge, Sweden.

    Veronica Lidell

    AlzeCure Pharma AB, Hälsovägen 7, 141 57, Huddinge, Sweden.

    Gunnar Nordvall

    AlzeCure Pharma AB, Hälsovägen 7, 141 57, Huddinge, Sweden.

    Division of Neuroscience, Care and Society, Department of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden.

    Maria Lindskog

    Division of Neuroscience, Care and Society, Department of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden.

    Sven-Ove Ögren

    Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.

    Pontus Forsell

    AlzeCure Pharma AB, Hälsovägen 7, 141 57, Huddinge, Sweden.

    Division of Neuroscience, Care and Society, Department of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden.

    Johan Sandin

    AlzeCure Pharma AB, Hälsovägen 7, 141 57, Huddinge, Sweden. johan.sandin@alzecurepharma.com.

    Division of Neuroscience, Care and Society, Department of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden. johan.sandin@alzecurepharma.com.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement